Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey

Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey

PURPOSEAccess to essential cancer medicines is a major determinant of childhood cancer outcomes globally. The degree to which pediatric oncologists deem medicines listed on WHO's Model List of Essential Medicines for Children (EMLc) essential is unknown, as is the extent to which such medicines...

Full description

Bibliographic Details
Main Authors: Avram E. Denburg, Adam Fundytus, Muhammad Saghir Khan, Scott C. Howard, Federico Antillon-Klussmann, Manju Sengar, Dorothy Lombe, Wilma Hopman, Matthew Jalink, Bishal Gyawali, Dario Trapani, Felipe Roitberg, Elisabeth G. E. De Vries, Lorenzo Moja, André Ilbawi, Richard Sullivan, Christopher M. Booth
Format: Article
Language:English
Published: American Society of Clinical Oncology 2022-06-01
Series:JCO Global Oncology
Online Access:https://ascopubs.org/doi/10.1200/GO.22.00034

Internet

https://ascopubs.org/doi/10.1200/GO.22.00034

Similar Items